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Abstract
Purpose of review The aim of this paper is to review and summarize the current knowledge
of prevention of airway allergy.
Recent findings Allergic rhinitis and asthma are allergic airway diseases. Due to
their increasing incidence and socioeconomic burden, allergic airway diseases
have recently gained attention worldwide. The primary prevention of allergic
airway diseases focuses on offspring’s gestational and childhood environment,
such as maternal smoking and diet during pregnancy and breastfeeding as well
as exposure to environmental microbes and irritants.
Summary Asthma and allergic rhinitis are a major public health problem world-
wide. They have increasing prevalence and thus attempts to their prevention are
mandatory. Rapid action needs to be taken to restrain smoking among children
and adolescents in order to prevent burden of allergic airway diseases. Exposure
to pollution and environmental issues concerning hygiene and lifestyle would also
need to be actively addressed. More evidence is still needed in order to draw
linings concerning maternal diet and other factors during the offspring’s whole
life span.
Introduction
Allergic rhinitis (AR) and atopic asthma are chronic in-
flammatory allergic airway diseases. AR is caused by al-
lergen binding to specific IgE in allergen-sensitized sub-
jects leading to rhinorrhea, obstruction, itch, sneeze, and
fatigue symptoms [1]. AR is connected to allergic and
non-allergic co-morbidities such as asthma, allergic con-
junctivitis, atopic dermatitis, and chronic rhinosinusitis
(CRS). Asthma is characterized by chronic inflammation
with mucus hypersecretion, edema, variable obstruction,
and fatigue. Asthma is not a single disease entity; it en-
compasses different phenotypes, both in children and
adults, and the most commonly described phenotypes
include allergic and non-allergic asthma [2]. Childhood
asthma is characterized by a predominance of allergic
multi-morbidity in males [3]. In adults, a large variety of
allergic and non-allergic asthma phenotypes exist with a
female predominance. Asthma can roughly be divided
into Th1- and Th2-high phenotypes. The latter includes
allergic and/or eosinophilic disorders varying from mild
to severe progressive forms. Severe eosinophilic forms,
such as acetylsalicylic acid (ASA-) exacerbated respiratory
disease (AERD), are more common in adults. Few ap-
proaches studied so far have shown encouraging signals
in prevention of asthma. Part of the problem and also the
solution may lie in over-simplification of terminology.
Asthma is a complex inflammatory disease which cannot
be considered a single entity. It is rather a heterogenous
dynamic immunological disorder strongly influenced by
gene/environment interactions.
AR and asthma are major public health problems
worldwide, with over 300 million people worldwide
affected [4, 5]. The prevalence of AR varies according to
previous studies between 15 and 50% of the population
[6, 7]. A recent Swedish study showed the prevalence of
AR at the age of 12 to be 13% [8]. Taking also in to
account that mild symptoms do not require medical
treatment and the fact that most of the patients outgrow
their allergy, especially concerning food allergy, the pre-
cise prevalence and therefore socioeconomic impact is
difficult to calculate. There is large variability of
particularly childhood asthma prevalence and incidence
in different parts of the world. After many decades of ever
increasing asthma rates in the Western world, we seem to
have recently reached a plateau and in some places even a
decrease at least in incidence from the beginning of 2000
in many developed countries. Children migrating from
low-income areas to higher socioeconomic areas have a
lower prevalence of asthma suggesting a critical time
window for childhood early in life. This implies to a
possibility to prevent asthma since there are obviously
biological predisposing factors influenced by the environ-
ment. On the other hand, there are biological borders,
likely genetic in nature, limiting the number of asthmatics
in the whole population. It should be kept in mind that
up to 85% of asthma patients have AR, and on the other
hand, 15–38% of AR patients have asthma [9].
There are five problems throughout the published
studies that are (1) small children have during respiratory
infections respiratory noises and parents label them often
as “wheeze” to please physicians’ obsession. However,
more than 30%of parents use other words and 30% label
other sounds for wheeze; (2) typically viral wheezers end
up getting control medication in most countries and they
are often maintained on this until school-age, despite
symptoms resolving with age. These children are counted
as asthmatics since they have “doctor diagnosed asthma”;
(3) most studies do not try to separate those with early
allergy and asthmatic symptoms from viral wheezers; (4)
many of the wheezers with more permanent phenotype
do not get the proper label of asthma; and (5) studies
rarely involve objective measurements.
Both atopic asthma and AR increase in population.
Megatrends such as climate change, population growth,
and urbanization might impact this increase [10] sug-
gesting strong environmental impact on disease devel-
opment in addition to its genetic predisposition. Pre-
vention of allergy is recommendable, since its socioeco-
nomic burden is heavy. The aim of this review is to
gather the current knowledge of primary prevention of
allergic airway diseases.
Smoking and allergic airway diseases
Exposure to passive tobacco smoke as well as active smoking among
adolescents and even children is amazingly high worldwide [11].
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Smoking during pregnancy is common, and estimated rates vary from
17 to 30% [12]. Cigarette smoking is the single largest modifiable risk
for all pregnancy-related morbidity and mortality [13, 14].
Numerous studies have confirmed the effect of external tobacco
smoke on the risk of asthma and also on the severity of bronchial
inflammation [15]. The most recent data indicate that this risk may be
even transmitted by possible epigenetic mechanisms over the generation
from grandmothers to grandchildren [16]. A recent meta-analysis found
that on adults, active smoking did not increase risk of AR, but increased
the risk for rhinitis. On the other hand, AR was associated with passive
smoking in adults. In children and adolescents, both active and passive
smoking increased the incidence of AR. The study group estimated that
14% of the AR is due to active smoking, therefore eliminating smoking
among young and children, every seventh case of AR could be prevented
[17]. Reduction of smoking, therefore, remains the easiest and one of
the most concrete ways of practical asthma prevention [18].
Studies have shown that maternal smoking during pregnancy increases the
risk for wheezing in childhood or asthma among offspring during early child-
hood [19], in preschool-age children [20], in adolescents [21], and in adults
[22]. These findings highlight the need for strategies to encourage women of
childbearing age and parents having children to permanently cease smoking in
order to decrease AR and asthma risk of offspring.
Allergen avoidance as prevention of airway allergy
It is not clear whether airway allergy can be prevented by allergen
avoidance in families having risk for allergic diseases. Most studies
aiming to reduce risk of asthma or allergy through controlling environ-
mental exposure to allergens are inconsistent and have failed. The Isle of
Wight study examined the effect of diets and extensive measures to
reduce exposure to house dust mite (HDM). This study with a relatively
small number of children (n = 120) considered at high risk for allergic
disorders is the only trial which has shown reduction of mite sensiti-
zation and asthma persisting until the age of 18 years [23]. The much
larger and more comprehensive Manchester study reported an opposite
effect on mite sensitization [24]. A randomized controlled trial was
performed in 2006, which found no decrease in asthma development
comparing HDM avoiding families and those without [25]. Another
study strengthened this theory by showing no differences in sensitization
or wheezing periods in children either avoiding the allergen or not,
according to dust samples [26]. An impaired lung function was shown
to develop on children with high exposure to indoor allergens early in
life compared to children without sensitization. On the other hand, high
amount of viral upper respiratory tract infections in the first years of life
may reduce the onset of asthma later in life [27].
At the moment, we do not fully understand the interaction between
allergic sensitization and disease, not to talk about the clinical relevance
of allergen exposure to development of asthma. It is clear that if an
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anaphylaxis has happened, then avoidance is recommendable. Also, in
secondary prevention, avoidance seems to have a role [28].
Inhaled indoor factors
HDM has been the most studied of indoor air particles in association with AR
prevention. Especially in the tropical countries, house dust mite allergy rate has
risen [29]. HDM allergy seems to be the most common cause for perennial AR
and bedroom environment is gaining more interest, as avoidance of the con-
tacts in sensitized individuals may lead to symptom relief. In the countries with
exposure to different allergens due to seasonal changes makes the diagnostics
more complex. A Cochrane review was conducted in 2010, in which seven
reports concluded that HDM load can be reduced with combination of acari-
cides and bedroom environmental control programs. Reduction of AR symp-
toms is poorly assessed in these reports, andmore specific studies are in request
[30, 31••]. Also, other factors as excessive moisture and volatile organic com-
pounds may play a role in airway allergy, but taken together, controversial
knowledge exists of the effect of indoor particles to development of AR or
asthma.
Outdoor environmental factors
Climate change and therefore air pollution is thought to be one of the main
reasons for increase of allergic diseases [10]. Especially, sulfur dioxide (SO2) is
shown to increase AR. Increase in the levels of SO2 correlated in the doctoral
consultations concerning AR [32]. In a cross-sectional questionnaire study, the
authors concluded that increase in the levels of SO2 increased the prevalence in
AR in Taiwanese school children [33]. Also, exposure to traffic-related pollutant
during pregnancy is shown to increase the incidence of AR, as well as asthma
and eczema [34]. Exposure to extreme heat has speculated to increase the
incidence of hay fever [35]. Taken together, evidence exists that outdoor air
pollution is associated with airway allergy.
Several studies reported nearly 20 years ago that children grown up in farm
environment develop less asthma and allergies. This effect has been studied
extensively and it is now contributed to contact with farm animals and their
microbes. The most recent studies from Amish and Hutterite populations
demonstrated that Amish children have much lower prevalence of asthma than
Hutterite children, despite the similarities in ancestry and most lifestyle factors
associated with asthma risk [36]. At the moment, the data suggest that airborne
substances likely derived from animals and their microbes shape innate im-
mune pathways to finally produce protection from asthma. Several trials are
now underway to examine whether for example bacterial lysates could prevent
development of asthma.
Probiotics, vitamin D, and obesity
During the last few decades, interest towards probiotics has risen. Several trials
have been able to demonstrate a clear decrease in risk of atopic eczema, when
Allergy Prevention (DY Wang, Section Editor)
both pregnant mothers and newborns have been given supplementation of
probiotic bacteria such as Bifidobacterium lactis or Lactobacillus rhamnosus. To
date, none of these trials have shown any sign of asthma prevention. It seems
that even atopic eczema dissociates from atopic sensitization. The central
biological and immunological mechanisms in development of asthma or
eczema may be distant [37]. A large (n = 4783) questionnaire study from
Poland confirmed that probiotics would not have any preventive effects on AR
when exposure is done in early childhood. In contrast, adolescents may benefit
from probiotics in prevention of allergic diseases, but their role remains unclear
[38].
In a recent systematic review, the role of vitamin D in primary prevention of
allergic diseases was assessed in four populations: pregnant and breastfeeding
mothers, infants, and older children. No clear association between D vitamin
and prevention of airway allergy was found [39, 40]. There is lacking knowledge
of the association between obesity and AR. In a Chinese survey study
(n = 4132), the prevalence of allergic rhinitis and atopic dermatitis was higher
among obese children compared to children with normal weight [41].
Perinatal dietary factors
During the breastfeeding-period and first months of life, nutrition of the baby is
regarded as a major factor in development of allergic diseases. Diet of pregnant
and lactating mothers as well as food introduction age are the major focuses of
the studies. There is not enough evidence on AR with dietary consumption of
the mom during the pregnancy or the breastfeeding period. It is shown that if
milking is not sufficient, highly hydrolyzed formulas of cow milk decrease the
incidence of atopic eczema, but not asthma or AR [42••]. Polyunsaturated fatty
acids (omega-3- and 6) were tested in a randomized controlled trial in Australia
and no significant difference on allergic disease onset was found between the
study groups [25]. Numerous follow-up cohorts have addressed the significance
of breastfeeding on development of asthma. The results have been often in-
consistent and the studies are often confounded by selection bias and reverse
causality. Even several meta-analysis studies done over the years have not been
able to solve the dilemmas and do not demonstrate a consistent protection
from asthma. It is, however, obvious that breastfeeding should be recom-
mended in all guidelines for many other health benefits [43].
Maternal nutrition
The nutrition of mothers during pregnancy: dietary patterns and selective
supplementation as well as levels of iron, vitamin D, folic acid, and
other nutrients may have protective as well as adverse effects on the
evolution of atopic diseases in the offspring [44]. However, all the
evidence is at the moment circumstantial and today only one published
trial on nutritional intervention of mothers has been able to show a
clear decrease in asthma risk. In a Danish study, pregnant mothers
received fish oil or placebo and their offsprings were followed for
3 years. The risk of the children’s persistent wheeze and infections of the
Primary Prevention of Airway Allergy Wikstén et al.
lower respiratory tract infections was reduced by approximately one
third [45].
Secondary prevention with immunotherapy
Only few studies have addressed the possibility to prevent asthma in those with
AR. The GAP trial is the only large, randomized, placebo-controlled study on
this subject. The investigators recruited 812 children between 5 and 12 years of
age with a grass pollen allergic rhinitis to a sublingual immunotherapy study
which comprised 3 years of treatment and 2 years of follow-up [46]. Although
the IT tablet reduced the risk for asthma symptoms and medication, there was
no difference in time to onset of asthma, leaving still the question openwhether
we truly can prevent this complex multifactorial disease by immunotherapy
against one allergen. One has to note that none of the studies with allergen-
specific immunotherapy have been able to show a change in the general
immunity from Th2 high to Th2 low, but the effect is always truly and only
allergen-specific.
Could asthma be prevented by preventing atopy?
Atopy is an important risk factor of asthma development and family history of
atopy is highly significant for development of atopy. It is, therefore, logical to
think that prevention of atopy would be of uttermost importance to prevent
asthma. However, we still understand poorly why up to 75% of teenage asth-
matics are atopic but much smaller degree of atopics are asthmatic [47, 48].
In the early days of atopy and asthma research, it was presumed that
most children would follow a pattern called “atopic march,” in other
words, asthma would succeed rhinitis which again is preceded by ecze-
ma and food allergy. In point prevalence, this concept looks valid. Also,
clinicians see small children often presenting with eczema and food
allergy and older children seem to acquire allergic asthma. However, in
the view of modern cohort studies, this is not the case in the majority
of asthmatic children. The most carefully done study examining this was
done in UK where two birth cohorts were combined producing a mas-
sive amount of data from more than 10.000 children. In this study
employing complex mathematical models, only 6% of the children with
any atopic disease followed the classical atopic march [49]. Moreover,
up to 70% of children with eczema do not progress to airway allergy.
It has been speculated if continuous washing of skin with soap brakes the
skin barrier by making the skin too dry and it has been suggested that if in the
early childhood, the skin was washed with creams instead of soap, the way of
the whole allergic march could be changed [50•].
Conclusions
Current knowledge of primary prevention of allergic airway diseases is limited,
except for smoking cessation. Childhood AR and asthma risk are increased by
exposure to smoking. Hence, asthma and AR offspring could be reduced and
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airway health could be improved by encouraging parents to permanently cease
smoking. There is limited or controversial knowledge of other environmental
factors and their effect on airway allergies.
Future needs
Western urbanization and lifestyle changes are claimed to be the main
reason for the increase of airway allergy [51–54]. There is a global need
of prevention of the current epidemics of chronic allergic respiratory
diseases. Studies on prediction and prevention of allergic diseases are
needed. Programs of better education and successes of children and
adults in the case of the prevalence and burden of allergic airway
diseases are needed, such as allergy programs [55]. This would increase
airway health and also general health and wellbeing.
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